Impedimed (ASX:IPD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Impedimed (ASX:IPD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change of Director's Interest Notice - Mr Andrew Grant
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Mr Erik Anderson
Application for quotation of securities - IPD
Notification of cessation of securities - IPD
Ceasing to be a substantial shareholder from AEF
Notification regarding unquoted securities - IPD
Update on Options and Holding Statements
Change in substantial holding
Change in substantial shareholding from AEF
Change in substantial holding
Change in Substantial Shareholding from AEF
Change of Director's Interest Notice - Mr Andew Grant
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Mr Erik Anderson
Top 20 Quoted Option Holders and Distribution Schedule
Notice under Section 708A(5)(e) of the Corporations Act
Application for quotation of securities - IPD
Results of Extraordinary General Meeting
Oversubscribed Share Purchase Plan Successfully Completed
ImpediMed completes oversubscribed $2.1 million Share Purchase Plan following $13.2 million placement
Change of Director's Interest Notice - Mr Erik Anderson
Change of Director's Interest Notice - Ms Fiona Bones
Change of Director's Interest Notice - Ms Janelle Delaney
Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Change of Director's Interest Notice - Mr Andrew Grant
Application for quotation of securities - IPD
Share Purchase Plan Close Date
CEO Business Update
ImpediMed updates on leadership, sales momentum, and strategic growth initiatives
Online Meeting Guide
Notice of Extraordinary General Meeting
Becoming a substantial holder
Share Purchase Plan - Letters to Shareholders
Share Purchase Plan Opens
Notice under Section 708A(5)(e) of the Corporations Act
Application for quotation of securities - IPD
Prospectus
Proposed issue of securities - IPD
Equity Raising Investor Presentation
ImpediMed launches AUD 15.2m equity raise to fund growth and debt reduction, targeting cashflow breakeven by H2 FY28
ImpediMed announces a successful $15.2 million Capital Raise
ImpediMed raises A$15.2 million, implements A$5 million cost cuts, targets FY28 cash flow breakeven
Trading Halt
Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
ImpediMed Q3 FY26 revenue $3.5M, expands US reimbursement, appoints new CEO to drive growth